Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Ioannis Kotsantis

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4666-4852; OpenAlex author ID A5072540862. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 4

  1. Phase Ib-II study of ramucirumab combined with nab-paclitaxel and Gemcitabine as first-line treatment in patients with advanced pancreatic adenocarcinoma (RACI… Co-author DOI 10.1016/j.ctarc.2026.101481↗
  2. Percutaneous Cryoneurolysis of Splanchnic Nerves for Pain Palliation in Patients with Pancreatic Cancer: A Single-Center Experience. First author DOI 10.1007/s00270-025-04142-3↗
  3. Computed Tomography-Guided Percutaneous Radiofrequency Ablation of the Splanchnic Nerves as a Single Treatment for Pain Reduction in Patients with Pancreatic C… Co-author DOI 10.3390/diagnostics11020303↗
  4. Extensive cutaneous metastases of pancreatic adenocarcinoma: a case report and review of the literature. Co-author DOI 10.1002/ccr3.737↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dimitrios K. Filippiadis · 2 shared papers, 2021–2025 · strength 0.43
  2. David‐Dimitris Chlorogiannis · 1 shared paper, 2025 · strength 0.28
  3. George Papaxoinis · 1 shared paper, 2026 · strength 0.25
  4. Elena Fountzilas · 1 shared paper, 2026 · strength 0.25
  5. George E. Pentheroudakis · 1 shared paper, 2026 · strength 0.25
  6. George Fountzilas · 1 shared paper, 2026 · strength 0.25
  7. Alexis Kelekis · 1 shared paper, 2021 · strength 0.15
  8. Stavros Grigoriadis · 1 shared paper, 2021 · strength 0.15
  9. Nikolaos K. Kentepozidis · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.